Possinger K - Search Results

1

A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells.

Liu DC, Zang CB, Liu HY, Possinger K, Fan SG, Elstner E. Liu DC, et al. Among authors: possinger k. Acta Pharmacol Sin. 2004 Oct;25(10):1312-9. Acta Pharmacol Sin. 2004. PMID: 15456533

2

Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma.

Zang C, Eucker J, Liu H, Coordes A, Lenarz M, Possinger K, Scholz CW. Zang C, et al. Among authors: possinger k. Leuk Lymphoma. 2014 Feb;55(2):425-34. doi: 10.3109/10428194.2013.806800. Epub 2013 Jul 25. Leuk Lymphoma. 2014. PMID: 23721513

3

Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.

Reinhardt A, Liu H, Ma Y, Zhou Y, Zang C, Habbel JP, Possinger K, Eucker J. Reinhardt A, et al. Among authors: possinger k. Anticancer Res. 2018 May;38(5):2669-2682. doi: 10.21873/anticanres.12509. Anticancer Res. 2018. PMID: 29715087

4

Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.

Liu H, Scholz C, Zang C, Schefe JH, Habbel P, Regierer AC, Schulz CO, Possinger K, Eucker J. Liu H, et al. Among authors: possinger k. Anticancer Res. 2012 May;32(5):1627-37. Anticancer Res. 2012. PMID: 22593441

5

The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.

Liu H, Zang C, Schefe JH, Schwarzlose-Schwarck S, Regierer AC, Elstner E, Schulz CO, Scholz C, Possinger K, Eucker J. Liu H, et al. Among authors: possinger k. Anticancer Res. 2011 Sep;31(9):2713-22. Anticancer Res. 2011. PMID: 21868512

6

Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells.

Zang C, Liu H, Bertz J, Possinger K, Koeffler HP, Elstner E, Eucker J. Zang C, et al. Among authors: possinger k. Mol Cancer Ther. 2009 Aug;8(8):2296-307. doi: 10.1158/1535-7163.MCT-09-0347. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671747

7

Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.

Bertz J, Zang C, Liu H, Wächter M, Possinger K, Koeffler HP, Elstner E. Bertz J, et al. Among authors: possinger k. Leuk Res. 2009 May;33(5):686-92. doi: 10.1016/j.leukres.2008.11.023. Epub 2009 Jan 7. Leuk Res. 2009. PMID: 19131110

8

Dual PPARalpha/gamma ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines.

Zang C, Liu H, Waechter M, Eucker J, Bertz J, Possinger K, Koeffler HP, Elstner E. Zang C, et al. Among authors: possinger k. Cell Cycle. 2006 Oct;5(19):2237-43. doi: 10.4161/cc.5.19.3259. Epub 2006 Oct 1. Cell Cycle. 2006. PMID: 17102607

9

Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD18.

Liu H, Zang C, Fenner MH, Liu D, Possinger K, Koeffler HP, Elstner E. Liu H, et al. Among authors: possinger k. Blood. 2006 May 1;107(9):3683-92. doi: 10.1182/blood-2005-05-2103. Epub 2006 Jan 10. Blood. 2006. PMID: 16403907

10

Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma.

Eucker J, Bängeroth K, Zavrski I, Krebbel H, Zang C, Heider U, Jakob C, Elstner E, Possinger K, Sezer O. Eucker J, et al. Among authors: possinger k. Anticancer Drugs. 2004 Nov;15(10):955-60. doi: 10.1097/00001813-200411000-00004. Anticancer Drugs. 2004. PMID: 15514564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results